Tackling the Global TB Crisis with Innovative AI Technology

Empowering Healthcare Providers with swift and non-invasive TB screening using a simple cough recording.

Download our Tuberculosis Brochure here:

Our TB brochure provides a simplified summary of our offerings and explains the workflow of how our technology works. You can download a copy here.

Revolutionizing TB Detection with Advanced AI Technology

Tuberculosis (TB) remains one of the top 10 causes of death worldwide. Despite advances in medicine, challenges in early detection and treatment adherence continue to hamper efforts to eliminate TB. Swaasa® leverages advanced AI technology to offer a non-invasive, cost-effective, and scalable solution for TB detection and monitoring

AI-Powered
Analysis

Non-Invasive and
Cost-Effective

Scalable and
Accessible

AI Platform built on cloud provides rich data for the doctors

Swaasa® records cough sounds and analyzes them for the possibility of TB along with a symptom’s questionnaire. Both these data points are processed by the proprietary engine that works in real time to produce rich data about a patient‘s respiratory condition. This makes monitoring possible and at scale.

Remote TB Screening using Swaasa® AI Platform

Here is a small summary of how the TB workflow work using the 

Frequently Asked Questions

What is Swaasa® AI Platform?

Swaasa® artificial intelligence platform (Swaasa® AI Platform) is Software as a Medical Device for screening and diagnostic aid in the assessment of respiratory diseases or conditions.

The Swaasa® AI platform is a cloud-based and non-invasive device intended to acquire, analyze, and store cough sounds along with symptoms. The device provides an informational report that is intended to be reviewed by a licensed healthcare professional as a screening tool and diagnostic aid in the assessment of respiratory conditions. 

The device is designed for use on adults (18 years and above) in hospitals, physician’s offices, laboratories, medical camps, and occupational health environments. The device can also be used for self-assessments with the direction of healthcare professionals. 

Swaasa® AI platform can also be integrated into other medical devices.

Swaasa® AI Platform is compliant with following regulations and standards.

Yes, Swaasa® has completed WHO defined clinical trials.

What indications does Swaasa® AI Platform provide?

The device provides an output which is functionally equivalent to a Spirometer. It outputs:   

  1. Respiratory disease pattern and its severity
  2. Spirometry values of FEV1, FVC and FEV1/FVC values

In addition the device also detects: 

  1. Presence of underlying respiratory problem (Normal vs Abnormal)
  2. Presence of disease conditions for Asthma and COPD.

Identification of pattern plays an important part in supporting diagnosis of respiratory conditions such as asthma, COPD etc.. There are four possible patterns of respiratory diseases: obstruction, restriction, mixed (obstruction and restriction) and normal.

Obstructive pattern lung diseases are a group of conditions that make it difficult for a person to completely exhale the air from their lungs. On the other hand, people with restrictive pattern lung diseases experience difficulty in fully expanding their lungs to take in air. Whereas in mixed pattern lung diseases, the total amount of air breathed in and breathed out are reduced.

Spirometry is a pulmonary function test that measures the amount and speed of air that a person can inhale and exhale. It is commonly used to assess lung function and diagnose respiratory conditions. Swaasa predicts the below key parameters based on cough characteristics.

  • Forced Expiratory Volume in 1 second (FEV1): FEV1 is the volume of air forcefully exhaled in the first second of a forced breath after maximal inhalation. FEV1 is a crucial indicator of how well the lungs are functioning, particularly in terms of expelling air forcefully.

  • Forced Vital Capacity (FVC): FVC is the total volume of air that can be forcefully exhaled after maximal inhalation.FVC provides information about the overall lung capacity and the ability to expel air forcefully.

  • FEV1/FVC Ratio: The FEV1/FVC ratio represents the proportion of the vital capacity expelled in the first second of forced expiration. This ratio is a key parameter in assessing and classifying obstructive and restrictive lung diseases.

These spirometric parameters help healthcare professionals evaluate lung function and identify patterns indicative of various respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and restrictive lung diseases. The interpretation of spirometry results involves comparing the measured values to predicted values based on age, sex and height, providing insights into the patient’s respiratory health.

Do I need to clean the phone after recording?

It is a good practice to clean the phone. Please follow these instructions to clean the phone: 

Using a soft microfibre cloth and disinfectant, wipe your phone clean.

Use damp cloth dipped in soapy waters for water proof phones

Use mobile sanitizers to clean your phone

  • Find a quiet place. Ensure while recording there is no background noise such as wind noise, fan and traffic.
  • Hold the phone with the microphone facing the subject / patient. Maintain a distance of 4-8 inches from the patient’s mouth.
  • Maintain a 90 degree angle with the face. 
  • Now you are ready to record the cough sounds.
    1.   Please cough multiple times.
    2.   Each time take a breath and cough.
    3.   Cough 3 to 4 times or until the recording stops.
  • Please feel free to wear a [surgical] mask.

The device can also be used for self-assessment at home based on the doctor’s discretion to send an assessment link to the patient. Patients must follow instructions while capturing data and recording the cough.

Taking self assessment at home is for your own well being. Hence it is important that you follow the instructions carefully to get genuine results.

In the interest of your own health and the health of our family and colleagues, it is required that the cough sample recorded is your own cough and not any other person’s.

Keep in mind that the system’s usefulness and effectiveness is dependent on the data submitted and correct answers and your own (patients’) authentic cough samples is what will give the most benefit to you and your family members.

What are the data and privacy issues to consider when using this product?

Swaasa® AI Platform uses anonymised data when integrated with 3rd party health service platforms. 

When used as a standalone device, users have to accept the End User License Agreement (EULA).

The data security and privacy are handled as per HIPAA compliance.

FAQs

For more detailed information on FAQs, click here to visit our page

Instructions for Use

To know more about instructions for usage, click here

For Support Purposes

Email: [email protected]
For customer support: +91 9154083835 +91 9154083839 +91 9154083840